NCT05101408

Brief Summary

Aphasia is a devastating acquired language impairment mainly caused by stroke, in which anomia is a quintessential clinical feature. If speech-language therapy (SLT) has been shown to be effective for persons with aphasia, the relative efficiency of one SLT strategy over another remains a matter of debate. The influential relationship between language, executive functions and aphasia rehabilitation outcomes has been addressed in a number of studies, but only few of them have studied the effect of adding an executive training to linguistic therapies.The aim of this study is to measure the efficiency of a protocol combining anomia therapy and executive training on naming skills and discourse in post-stroke aphasic persons at the chronic stage

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 1, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

April 12, 2022

Status Verified

April 1, 2022

Enrollment Period

3 months

First QC Date

October 19, 2021

Last Update Submit

April 11, 2022

Conditions

Keywords

AphasiaSpeech-Language TherapyAnomiaExecutive functions

Outcome Measures

Primary Outcomes (2)

  • Evolution of individual naming scores

    Evolution of individual naming scores during baseline and treatment phases Participants are asked to name pictures from a personal naming task constituted of 100 black and white pictures and scores are expressed as percent of correct responses (min 0, max 100): higher percents meaning a better outcome. A visual analysis of the evolution of these scores along the course of the treatment will be conducted.

    2 days

  • Comparison of discourse

    Comparison of discourse scores before and after the treatment For each participant, four different samples of discourse are elicited before and after the treatment (picture description, personal narrative, book supported narrative, procedural information). The mean number of correct words per minute is then computed for each participant, and compared between the two time points, higher scores meaning a better outcome.

    2 days

Secondary Outcomes (1)

  • Comparison of executive scores

    2 days

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Person with post-stroke aphasia at the chronic stage, receiving SLT rehabilitation

You may qualify if:

  • \< age \> 80 years
  • adult person with chronic post-stroke aphasia (\> 6 months postonset)
  • receiving SLT rehabilitation 3 times a Week

You may not qualify if:

  • presence of apraxia of speech
  • major impairment of comprehension
  • history of other neurological or psychiatric disease
  • presence of apraxia of speech
  • presence of major impairment of comprehension
  • presence of history of other neurological or psychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

AnomiaAphasiaCommunication Disorders

Condition Hierarchy (Ancestors)

Language DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpeech DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Sylvie Moritz-Gasser

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2021

First Posted

November 1, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 30, 2021

Last Updated

April 12, 2022

Record last verified: 2022-04

Locations